Cite
HARVARD Citation
Peddi, P. et al. (n.d.). Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential. Therapeutic advances in medical oncology. pp. 202-209. [Online].